Clinical Trial Update: DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describes a study evaluating dendritic cell migration and regulatory T cell depletion in glioblastoma patients, with and without…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Varlilumab (varlilumab)

Snippet

Sponsor: Annick Desjardins, MD | Conditions: Glioblastoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING